The application of adjuvant autologous antravesical macrophage cell therapy vs. BCG in non-muscle invasive bladder cancer: a multicenter, randomized trial

INTRODUCTION: While adjuvant immunotherapy with Bacille Calmette Guérin (BCG) is effective in non-muscle-invasive bladder cancer (BC), adverse events (AEs) are considerable. Monocyte-derived activated killer cells (MAK) are discussed as essential in antitumoural immunoresponse, but their application...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Burger, Maximilian, Thiounn, Nicolas, Denzinger, Stefan, Kondas, Jozsef, Benoit, Gerard, Chapado, Manuel S, Jimenz-Cruz, Fernando J, Kisbenedek, Laszlo, Szabo, Zoltán, Zsolt, Domján, Grimm, Marc O, Romics, Imre, Thüroff, Joachim W, Kiss, Tamas, Tombal, Bertrand, Wirth, Manfred, Munsell, Marc, Mills, Bonnie, Koh, Tung, Sherman, Jeff
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2010
Teme:
Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2893125/
https://ncbi.nlm.nih.gov/pubmed/20529333
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-8-54
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items